Greater patient involvement is among the stated aims of the ABPI, so why do companies up and down the country say the association’s Code of Conduct makes engagement difficult?
Collaboration between pharma and patient organisations can yield fantastic results – but conflict of interest concerns can stop such potential-filled partnerships getting off the ground.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
